| Followers | 0 |
| Posts | 3251 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Monday, July 21, 2025 8:15:33 AM
Billing cycle HERE 👇️
https://resources.investorvillage.com/uploads/88540/files/advent.pdf
You obviously have no idea how this works. How much due diligence did you actually do?
PS. Flaskworks is nowhere near ready and it wasn't used/tested in the phase 3 trial.. Therefore, I do not believe it can be used without another confirmatory trial using that machine, if it ever actually comes to be... and.... Grade C labs are far away from being built.
You're CEO owns Advent privately, I don't think she will preclude them from any potential future business.
Advent does the billing, not NWBO.
You can's just walk in and buy vaccines like you can buy loosie cigarettes in a Bodega. ... lol.
Mind you, that is AFTER NICE is already paying for surgery, chemo and radiation (SOC)... which is not exactly peanuts.
For those who don't know what a loosie is:
A loosie (or loosey) is a single cigarette that is sold individually, rather than in a pack of 20, which is the legal requirement in the United States. These are often found in low-income areas
https://resources.investorvillage.com/uploads/88540/files/advent.pdf
You obviously have no idea how this works. How much due diligence did you actually do?
PS. Flaskworks is nowhere near ready and it wasn't used/tested in the phase 3 trial.. Therefore, I do not believe it can be used without another confirmatory trial using that machine, if it ever actually comes to be... and.... Grade C labs are far away from being built.
You're CEO owns Advent privately, I don't think she will preclude them from any potential future business.
Advent does the billing, not NWBO.
You can's just walk in and buy vaccines like you can buy loosie cigarettes in a Bodega. ... lol.
Mind you, that is AFTER NICE is already paying for surgery, chemo and radiation (SOC)... which is not exactly peanuts.
For those who don't know what a loosie is:
A loosie (or loosey) is a single cigarette that is sold individually, rather than in a pack of 20, which is the legal requirement in the United States. These are often found in low-income areas
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
